Literature DB >> 15096183

Conventional protein kinase C and atypical protein kinase Czeta differentially regulate macrophage production of tumour necrosis factor-alpha and interleukin-10.

Andrew D Foey1, Fionula M Brennan.   

Abstract

In chronic inflammatory diseases such as rheumatoid arthritis, joint macrophages/monocytes are the major source of pro- and anti-inflammatory cytokines. Little is understood regarding the signalling pathways which determine the production of the pro-inflammatory cytokine, tumour necrosis factor-alpha (TNF-alpha) and the anti-inflammatory cytokine, interleukin-10 (IL-10). Two pathways integral to macrophage function are the protein kinase C (PKC)- and the cAMP-dependent pathways. In this report, we have investigated the involvement of PKC and cAMP in the production of TNF-alpha and IL-10 by peripheral blood monocyte-derived macrophages. The utilization of the PKC inhibitors Go6983, Go6976 and RO-32-0432 demonstrated a role for conventional PKCs (alpha and beta) in the production of TNF-alpha in response to stimulation by lipopolysaccharide and phorbol 12-myristate 13-acetate (PMA)/ionomycin. PKC stimulation resulted in the downstream activation of the p42/44 mitogen-activated protein kinase (MAPK) pathway which differentially regulates TNF-alpha and IL-10. The addition of cAMP however, suppressed activation of this MAPK and TNF-alpha production. Cyclic-AMP augmented IL-10 production and cAMP response element binding protein activation upon stimulation by PMA/ionomycin. In addition, cAMP activated PKCzeta; inhibition of which, by a dominant negative adenovirus construct, selectively suppressed IL-10 production. These observations suggest that pro-inflammatory and anti-inflammatory cytokines are differentially regulated by PKC isoforms; TNF-alpha being dependent on conventional PKCs (alpha and beta) whereas IL-10 is regulated by the cAMP-regulated atypical PKCzeta.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15096183      PMCID: PMC1782472          DOI: 10.1111/j.1365-2567.2004.01852.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  43 in total

Review 1.  Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling.

Authors:  M D Houslay; W Kolch
Journal:  Mol Pharmacol       Date:  2000-10       Impact factor: 4.436

2.  Protein kinase C-alpha participates in FcgammaR-mediated phagocytosis in macrophages.

Authors:  A Breton; A Descoteaux
Journal:  Biochem Biophys Res Commun       Date:  2000-09-24       Impact factor: 3.575

3.  ERK2 mitogen-activated protein kinase binding, phosphorylation, and regulation of the PDE4D cAMP-specific phosphodiesterases. The involvement of COOH-terminal docking sites and NH2-terminal UCR regions.

Authors:  S J MacKenzie; G S Baillie; I McPhee; G B Bolger; M D Houslay
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

4.  Cyclic adenosine monophosphate-responsive elements are involved in the transcriptional activation of the human IL-10 gene in monocytic cells.

Authors:  C Platzer; E Fritsch; T Elsner; M H Lehmann; H D Volk; S Prösch
Journal:  Eur J Immunol       Date:  1999-10       Impact factor: 5.532

Review 5.  New insights into the regulation of protein kinase C and novel phorbol ester receptors.

Authors:  D Ron; M G Kazanietz
Journal:  FASEB J       Date:  1999-10       Impact factor: 5.191

6.  betac cytokine receptor-induced stimulation of cAMP response element binding protein phosphorylation requires protein kinase C in myeloid cells: a novel cytokine signal transduction cascade.

Authors:  E Gubina; X Luo; E Kwon; K Sakamoto; Y F Shi; R A Mufson
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

7.  Differential redistribution of protein kinase C isoforms by cyclic AMP in HL60 cells.

Authors:  B G Miguel; M C Calcerrada; F Mata; P Aller; R Clemente; R E Catalán; A M Martínez
Journal:  Biochem Biophys Res Commun       Date:  2000-08-11       Impact factor: 3.575

8.  Protein kinase C zeta plays a central role in activation of the p42/44 mitogen-activated protein kinase by endotoxin in alveolar macrophages.

Authors:  M M Monick; A B Carter; D M Flaherty; M W Peterson; G W Hunninghake
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

9.  Cyclooxygenase-2 expression in macrophages: modulation by protein kinase C-alpha.

Authors:  M Giroux; A Descoteaux
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

10.  Protein kinase C (PKC)-alpha activation inhibits PKC-zeta and mediates the action of PED/PEA-15 on glucose transport in the L6 skeletal muscle cells.

Authors:  G Condorelli; G Vigliotta; A Trencia; M A Maitan; M Caruso; C Miele; F Oriente; S Santopietro; P Formisano; F Beguinot
Journal:  Diabetes       Date:  2001-06       Impact factor: 9.461

View more
  12 in total

1.  Inhibition of classical PKC isoenzymes downregulates STAT1 activation and iNOS expression in LPS-treated murine J774 macrophages.

Authors:  Tiina Salonen; Outi Sareila; Ulla Jalonen; Hannu Kankaanranta; Raimo Tuominen; Eeva Moilanen
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

2.  Choline transport links macrophage phospholipid metabolism and inflammation.

Authors:  Shayne A Snider; Kaitlyn D Margison; Peyman Ghorbani; Nicholas D LeBlond; Conor O'Dwyer; Julia R C Nunes; Thao Nguyen; Hongbin Xu; Steffany A L Bennett; Morgan D Fullerton
Journal:  J Biol Chem       Date:  2018-06-07       Impact factor: 5.157

3.  Longitudinal relationships between rheumatoid factor and cytokine expression by immunostimulated peripheral blood lymphocytes from patients with rheumatoid arthritis: New insights into B-cell activation.

Authors:  John M Davis; Cynthia S Crowson; Keith L Knutson; Sara J Achenbach; Michael A Strausbauch; Terry M Therneau; Eric L Matteson; Sherine E Gabriel; Peter J Wettstein
Journal:  Clin Immunol       Date:  2020-01-08       Impact factor: 3.969

4.  Inhibition of the PKCγ-ε pathway relieves from meningeal nociception in an animal model: an innovative perspective for migraine therapy?

Authors:  Nicoletta Galeotti; Carla Ghelardini
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

5.  Prenatal alcohol exposure potentiates chronic neuropathic pain, spinal glial and immune cell activation and alters sciatic nerve and DRG cytokine levels.

Authors:  Shahani Noor; Joshua J Sanchez; Arden G Vanderwall; Melody S Sun; Jessie R Maxwell; Suzy Davies; Lauren L Jantzie; Timothy R Petersen; Daniel D Savage; Erin D Milligan
Journal:  Brain Behav Immun       Date:  2016-12-20       Impact factor: 7.217

6.  Encapsulated Streptococcus suis inhibits activation of signaling pathways involved in phagocytosis.

Authors:  Mariela Segura; Marcelo Gottschalk; Martin Olivier
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

7.  Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease.

Authors:  Rachel H McMahan; Xiaoxin X Wang; Lin Ling Cheng; Tibor Krisko; Maxwell Smith; Karim El Kasmi; Mark Pruzanski; Luciano Adorini; Lucy Golden-Mason; Moshe Levi; Hugo R Rosen
Journal:  J Biol Chem       Date:  2013-03-04       Impact factor: 5.157

8.  Protein kinase C and toll-like receptor signaling.

Authors:  Daniel J Loegering; Michelle R Lennartz
Journal:  Enzyme Res       Date:  2011-08-23

9.  Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages.

Authors:  Khalil Karimi; Hadi Sarir; Esmaeil Mortaz; Joost J Smit; Hossein Hosseini; Sjef J De Kimpe; Frans P Nijkamp; Gert Folkerts
Journal:  Respir Res       Date:  2006-04-19

10.  Tumor necrosis factor alpha and epidermal growth factor act additively to inhibit matrix gene expression by chondrocyte.

Authors:  Aaron R Klooster; Suzanne M Bernier
Journal:  Arthritis Res Ther       Date:  2004-11-29       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.